Manulife (Manufacturers Life Insurance)’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,618
| Closed | -$297K | – | 3034 |
|
|
2022
Q3 | $297K | Sell |
19,618
-558
| -3% | -$6.49K | ﹤0.01% | 2316 |
|
|
2022
Q2 | $151K | Buy |
20,176
+1,226
| +6% | +$8.64K | ﹤0.01% | 2787 |
|
|
2022
Q1 | $172K | Sell |
18,950
-5,139
| -21% | -$39.6K | ﹤0.01% | 2827 |
|
|
2021
Q4 | $169 | Buy |
24,089
+297
| +1% | +$3.11K | ﹤0.01% | 2953 |
|
|
2021
Q3 | $271K | Sell |
23,792
-1,203
| -5% | -$17.6K | ﹤0.01% | 2752 |
|
|
2021
Q2 | $400K | Buy |
24,995
+3,235
| +15% | +$55.5K | ﹤0.01% | 2591 |
|
|
2021
Q1 | $389K | Sell |
21,760
-1,594
| -7% | -$27.5K | ﹤0.01% | 2448 |
|
|
2020
Q4 | $316K | Buy |
23,354
+897
| +4% | +$10.8K | ﹤0.01% | 2485 |
|
|
2020
Q3 | $264K | Hold |
22,457
| – | – | ﹤0.01% | 2389 |
|
|
2020
Q2 | $335K | Sell |
22,457
-4,873
| -18% | -$72.1K | ﹤0.01% | 2173 |
|
|
2020
Q1 | $369K | Buy |
27,330
+1,832
| +7% | +$34.8K | ﹤0.01% | 1978 |
|
|
2019
Q4 | $616K | Sell |
25,498
-866
| -3% | -$17.9K | ﹤0.01% | 1931 |
|
|
2019
Q3 | $536K | Sell |
26,364
-29
| -0.1% | -$664 | ﹤0.01% | 1975 |
|
|
2019
Q2 | $780K | Buy |
26,393
+3,014
| +13% | +$116K | ﹤0.01% | 1779 |
|
|
2019
Q1 | $1.11M | Buy |
23,379
+1,769
| +8% | +$77.9K | ﹤0.01% | 1632 |
|
|
2018
Q4 | $781K | Sell |
21,610
-1,548
| -7% | -$72.6K | ﹤0.01% | 1703 |
|
|
2018
Q3 | $1.43M | Sell |
23,158
-3,276
| -12% | -$211K | ﹤0.01% | 1592 |
|
|
2018
Q2 | $1.79M | Buy |
26,434
+1,025
| +4% | +$57.3K | ﹤0.01% | 1538 |
|
|
2018
Q1 | $1.38M | Buy |
25,409
+130
| +0.5% | +$7.27K | ﹤0.01% | 1662 |
|
|
2017
Q4 | $1.51M | Buy |
25,279
+381
| +2% | +$23.1K | ﹤0.01% | 1613 |
|
|
2017
Q3 | $1.21M | Buy |
24,898
+1,397
| +6% | +$76.2K | ﹤0.01% | 1678 |
|
|
2017
Q2 | $1.24M | Buy |
23,501
+1,235
| +6% | +$57.5K | ﹤0.01% | 1682 |
|
|
2017
Q1 | $1.01M | Buy |
22,266
+3,410
| +18% | +$152K | ﹤0.01% | 1731 |
|
|
2016
Q4 | $714K | Buy |
18,856
+1,970
| +12% | +$74.5K | ﹤0.01% | 1875 |
|
|
2016
Q3 | $637K | Sell |
16,886
-152
| -0.9% | -$3.35K | ﹤0.01% | 1927 |
|
|
2016
Q2 | $300K | Buy |
17,038
+2,907
| +21% | +$47.1K | ﹤0.01% | 2388 |
|
|
2016
Q1 | $171K | Buy |
14,131
+698
| +5% | +$11K | ﹤0.01% | 2709 |
|
|
2015
Q4 | $327 | Buy |
13,433
+157
| +1% | +$3.66K | ﹤0.01% | 2311 |
|
|
2015
Q3 | $236 | Hold |
13,276
| – | – | ﹤0.01% | 2507 |
|
|
2015
Q2 | $234 | Buy |
13,276
+5,888
| +80% | +$108K | ﹤0.01% | 2730 |
|
|
2015
Q1 | $231 | Buy |
7,388
+176
| +2% | +$5.1K | ﹤0.01% | 2627 |
|
|
2014
Q4 | $210 | Sell |
7,212
-133
| -2% | -$3.37K | ﹤0.01% | 2603 |
|
|
2014
Q3 | $152 | Sell |
7,345
-217
| -3% | -$4.28K | ﹤0.01% | 2825 |
|
|
2014
Q2 | $188K | Buy |
7,562
+1,023
| +16% | +$17.7K | ﹤0.01% | 2759 |
|
|
2014
Q1 | $139 | Buy |
+6,539
| New | +$132K | ﹤0.01% | 2926 |
|
Manulife (Manufacturers Life Insurance)'s AERI Position: Q4 2022 in Review
Manulife (Manufacturers Life Insurance) sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 19,618 shares — an estimated $297K sold.
Manulife (Manufacturers Life Insurance) first reported a position in AERI in Q1 2014 and held it in 35 quarters. The position peaked at $1.79M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Manulife (Manufacturers Life Insurance) reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 19,618 Aerie Pharmaceuticals shares in Q4 2022, an estimated $297K.
- Manulife (Manufacturers Life Insurance) first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 35 quarters.
- Manulife (Manufacturers Life Insurance)'s Aerie Pharmaceuticals position peaked at $1.79M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.